Innovaprep
Drexel, US · Founded 2018 · Delaware corporation
Biotech
Founders & leadership
DS
David S AlburtyExecutive Officer, Director
KR
Kathleen RuegseggerExecutive Officer, Director
AE
Andrew E PageExecutive Officer, Director
MH
Michael HeckmanDirector
PB
Paul BertrandDirector
Reported raises · per SEC filings
Form D private placements▶$100KraisedDec 2025 · 2 investors · BiotechnologyRule 506(b)
▶$100KraisedDec 2025 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael HeckmanDirector
- David S AlburtyExecutive Officer, Director
- Paul BertrandDirector
- Kathleen RuegseggerExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $100K
- Minimum investment
- $25K
- First sale
- Dec 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedFeb 2022 · 3 investors · BiotechnologyRule 506(b)
▶$1MraisedFeb 2022 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael HeckmanDirector
- David S AlburtyExecutive Officer, Director
- Paul BertrandDirector
- Kathleen RuegseggerExecutive Officer
- Carol A PranulisDirector
- Andrew E PageExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $1M
- Minimum investment
- $50K
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$500KraisedMar 2020 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedMar 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David S AlburtyExecutive Officer, Director
- Andrew E PageExecutive Officer, Director
- Offering amount
- $750K
- Amount sold
- $500K
- Minimum investment
- $276.2K
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$2.1MraisedSep 2018 · 3 investors · BiotechnologyRule 506(b)
▶$2.1MraisedSep 2018 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David S AlburtyExecutive Officer, Director
- Andrew E PageExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2.1M
- Minimum investment
- $110.2K
- Proceeds to insiders
- $272K
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 9 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Oceanic and Atmospheric Administration (NOAA)National Oceanic and Atmospheric Administration | Phase II | 2019 | $399.9K |
| National Oceanic and Atmospheric Administration (NOAA)National Oceanic and Atmospheric Administration | Phase I | 2018 | $120K |
| NASA | Phase II | 2016 | $749.4K |
| NASA | Phase I | 2016 | $121.7K |
| NASA | Phase I | 2015 | $125K |
| Food and Drug Administration (FDA)Food and Drug Administration | Phase II | 2013 | $676K |
| Department of Homeland Security | Phase II | 2012 | $750K |
| Food and Drug Administration (FDA)Food and Drug Administration | Phase I | 2011 | $150K |
| Department of Homeland Security | Phase I | 2011 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.